Ultragenyx

Ultragenyx

RARE · NASDAQ
RARE · NASDAQ
15.30
USD-0.98-6.05%

Latest News

    @Investingcom
    Investingcom

    *CHINA RESUMES RARE EARTH EXPORTS TO JAPAN 🇨🇳🇯🇵 https://t.co/InZtq24m73

      @Investingcom
      Investingcom

      *USA RARE EARTH ANNOUNCES LETTER OF INTENT WITH US GOVERNMENT *USA RARE EARTH GETS ACCESS TO $1.6 BILLION IN FUNDING $USAR https://t.co/krvcAOmabd

        @Investingcom
        Investingcom

        *CHINA DECEMBER RARE EARTH MAGNETS EXPORTS TO THE UNITED STATES DOWN 3% ON MONTH TO 564 METRIC TONS 🇺🇸🇨🇳 https://t.co/GBFaO2yMms

          CoinOtag

          RARE: Rise or Fall? January 16, 2026 Scenario Analysis

            CoinOtag

            RARE January 16, 2026: Critical Resistance Test in Sideways Trend and Breakout Potential

              CoinOtag

              RARE: Rise or Fall? January 15, 2026 Scenario Analysis

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              15.30USD
              17.00USD

              52 Week Range

              12.73USD
              39.89USD

              Market Cap

              1.59BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US90400D1081

              CUSIP

              90400D108

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -0.24

              Book Value

              -2.96

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -5.82

              Wall Street Target Price

              26.25

              EPS Estimate Current Year

              -4.08

              EPS Estimate Next Year

              0.23

              EPS Estimate Current Quarter

              -0.9971

              EPS Estimate Next Quarter

              -0.7337

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              717,000,000

              Gross Profit TTM

              -149,000,000

              EBITDA

              -465,000,000

              Profit Margin

              -81.73%

              Return On Assets TTM

              -24.22%

              Return On Equity TTM

              -608.47%

              Revenue Per Share TTM

              7.131

              Qtly Revenue Growth YOY

              28.10%

              Diluted Eps TTM

              -5.82

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              2.2413

              Price Book MRQ

              19.6838

              Enterprise Value Revenue

              1

              Enterprise Value EBITDA

              -6

              Peers analysis

              • argenx NV ADR
                ARGXargenx NV ADR

                903.08

                3.20%
              • Moderna Inc
                MRNAModerna Inc

                227.40

                2.97%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                965.00

                0.55%
              • UCB SA
                UCBJFUCB SA

                314.92

                0.35%
              • argenx SE
                ARGNFargenx SE

                900.30

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                139.16

                0.00%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                528.21

                -4.77%
              • Be
                ONCBeiGene, Ltd.

                355.10

                -2.26%
              • CSL Ltd
                CSLLYCSL Ltd

                34.64

                -2.01%
              • UCB SA ADR
                UCBJYUCB SA ADR

                153.70

                -1.47%

              FAQs

              What is Ultragenyx stock price today?

              What is Ultragenyx stock ticker?

              Is RARE stock price going up?

              What is the analyst recommendation for RARE?

              What is RARE market cap?

              Does RARE release financial reports?

              When is RARE next earnings date?

              What were RARE Earnings for the last quarter?

              What was RARE Revenue for the last quarter?

              What was RARE Net Income for the last quarter?

              Does RARE pay dividends?

              How many employees does RARE have?

              What is RARE EBITDA?

              How to buy RARE stocks?

              Should I invest in RARE stock?